COMMUNIQUÉS West-GlobeNewswire

VALNEVA : Bilan Semestriel du contrat de liquidité de Valneva SE
04/01/2019
Paris, le 4 janvier 2019 Bilan semestriel du contrat de liquidité VALNEVA contracté avec ODDO & Cie Au titre du contrat de liquidité confié à Oddo Corporate Finance portant sur les actions de la société VALNEVA, à [...]
Spineway: Subscription of 2nd tranche of 100 bonds for a par value of €1M as per the Additional Commitment
04/01/2019
Spineway Subscription of 2nd tranche of 100 bonds convertible into new and/or existing shares ( OCEANE ) with attached warrants for a par value of €1M as per the Additional Commitment. Spineway (the “ Company ”) [...]
Spineway: Souscription de la 2ème tranche de 100 obligations pour un montant nominal d’1 MEUR au titre de l’Engagement Complémentaires
04/01/2019
SPINEWAY Souscription de la 2ème tranche de 100 obligations convertibles ou échangeables en actions nouvelles et/ou existantes (OCEANE) assorties de bons de souscription d’actions pour un montant nominal d’1 MEUR au [...]
111, Inc. Signs Online Healthcare Project Strategic Framework Agreement with the Kunshan Health Commission
04/01/2019
SHANGHAI, Jan. 04, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online-offline healthcare platform, announced today the signing of a strategic framework agreement with [...]
GeneSight® GUIDED Study Published in the Journal of Psychiatric Research
04/01/2019
Large, Blinded Prospective Study Demonstrates that GeneSight Improves Clinical Outcomes in Patients with Treatment Resistant Major Depressive Disorder SALT LAKE CITY, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, [...]
Vericel Reports Publication of Outcomes Data From 954 Burn Patients Treated With Epicel in the Journal of Burn Care and Research
04/01/2019
Results Demonstrate an Increased Survival Rate for Patients Treated with Epicel CAMBRIDGE, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leader in advanced cell therapies for the sports [...]
Indiana Minority Health Coalition in Partnership to Host Second Statewide Town Hall Meeting on Infant Mortality in the Black Community
04/01/2019
Co-Sponsors Include Side Effects Media and the Indianapolis Recorder INDIANAPOLIS, Jan. 04, 2019 (GLOBE NEWSWIRE) -- The Indiana Minority Health Coalition (IMHC) in partnership with Side Effects Media and the [...]
Syneos Health to Share Critical Insights for Maximizing Value and Fueling Commercial Success at Biotech Showcase Events
04/01/2019
Company to Release New Survey Findings from C-Suite Leaders on Commercial Spend and Planning and Essentials for a Successful Launch MORRISVILLE, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the [...]
Femasys Announces First 100 Women Treated in Pivotal Clinical Trial with FemBloc® Permanent Contraceptive System
04/01/2019
ATLANTA, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Femasys, Inc., a medical technology company developing a platform of innovative in-office solutions for women’s healthcare today announced that the first 100 woman in the BLOC [...]
OrthoPediatrics Corp. Announces Direct Sales Agency Expansion in Belgium and the Netherlands
04/01/2019
WARSAW, Ind., Jan. 04, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today their recently [...]
HMS Hires Robert P. Borchert as New Investor Relations Officer
04/01/2019
IRVING, Texas, Jan. 04, 2019 (GLOBE NEWSWIRE) -- HMS Holdings Corp (Nasdaq:HMSY) today announced that Robert P. Borchert has joined the Company as Senior Vice President, Investor Relations. He succeeds Dennis Oakes, who [...]
Diffusion Pharmaceuticals Chief Executive Officer David Kalergis to Present at 37th Annual J.P. Morgan Healthcare Conference
04/01/2019
Industry’s Largest Symposium Brings Over 9,000 Attendees to San Francisco CHARLOTTESVILLE, Va., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) , a cutting-edge biotechnology company [...]
La Jolla Pharmaceutical Company to Present at the 37th Annual J.P. Morgan Healthcare Conference
04/01/2019
SAN DIEGO, Jan. 04, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
Affimed to Present at the 37th Annual J.P. Morgan Healthcare Conference
04/01/2019
Heidelberg, Germany, January 4, 2019 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company committed to improving patient outcomes through the power of the innate immune system, today announced that [...]
Tauriga Sciences Inc. Reveals Several of the Specific & Differentiating Features Integrated into its Cannabis/CBD Infused Chewing Gum Product Line
04/01/2019
New York, NY, Jan. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. ( TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]
Ultragenyx Announces Positive Topline Results from First Cohort of Phase 1/2 Clinical Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
04/01/2019
DTX401 Response Observed in All Three Patients, with Two Patients Demonstrating Clinically Meaningful Improvement in Time to Hypoglycemia Study to Advance to Cohort 2 at a Higher Dose NOVATO, Calif., Jan. 04, 2019 ( [...]
Resonant Inc. to Present at the 21st Annual Needham Growth Conference
04/01/2019
GOLETA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless [...]
BioCryst Appoints Steve Aselage to Board of Directors
04/01/2019
RESEARCH TRIANGLE PARK, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed Steve Aselage to its board of directors. Mr. Aselage most [...]
Surface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory Board
04/01/2019
CAMBRIDGE, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]

Pages